Company Information

Management Team

Justin Schreiber

President, Chief Executive Officer, Director

Mr. Schreiber is the founder of JLS Ventures, LLC, a San Juan based venture investment and advisory firm that specializes in emerging growth publicly traded healthcare and technology companies. He has a deep background in small cap markets, private equity, trading, and online marketing. Mr. Schreiber is an entrepreneur with an accomplished track record in technology and direct response marketing.

Stefan Galluppi

Chief Operating Officer, Chief Technology Officer, Director

Mr. Galluppi has an extensive background in direct to consumer marketing. In addition to building proprietary technology to facilitate and optimize advertising campaigns for maximum efficiency and profitability. Mr. Galluppi was also instrumental in helping create the framework for an optimal back-end office infrastructure which supported multiple National TV direct response advertising campaigns rated among the top 10 on the national TV IMS report rankings for performance.

Juan Manuel Piñeiro Dagnery

Chief Financial Officer

Juan Manuel Piñeiro Dagnery, age 31, carries extensive experience within various industries ranging from finance, wealth management and investment banking to direct-marketing and analytics for public companies. He combines over 8 years of experience in financial and operations management with prior roles as an equity analyst at UBS Financial Services of Puerto Rico from 2010 to 2013, director at One Equity Research LLC from 2014 to 2016 and controller at Conversion Labs, Inc. since July 2016. He received a Bachelor of Business Administration in Finance at Inter American University of Puerto Rico in 2012.

Sean Fitzpatrick

Chief Acquisition Officer

Mr. Fitzpatrick is a leader in direct response marketing, specializing in the legal, lifestyle and software as a service (SAAS) verticals. Most recently, he was Head of Customer Acquisition at BOLD, an online company in the career space that connected jobseekers with recruiters. While at BOLD, he created a brand new integrated department that tripled net revenue in four years. His 20 person customer acquisition team included SEM, SEO, affiliate marketing, social marketing and content marketing specialists for the B2C and B2B markets.

Joseph V. DiTrolio, MD

Chief Medical Officer - U.S., Director

Joseph V. DiTrolio, MD, is a Diplomate of the American Board of Urology, a Clinical Professor of Surgery, Division of Urology at New Jersey Medical School, the Treasurer, Board of Governors for the Stone Center of New Jersey, and the immediate past Chairman of the Department of Urology for the St. Barnabas Medical Center Healthcare System.

Dr. DiTrolio has served as a medical consultant for Fortune 500 Healthcare companies including Novartis, Sanofi-Aventis, AstraZeneca, Allergan, et al. He is also the current Medical Director for OneMedPlace. He is the holder of several patents.

Dr. DiTrolio’s experience across patient care, clinical research, and new product development brings great value to iNR Wellness MD as the Company prepares to rollout new dietary supplement product lines through physician networks and practices. Dr. DiTrolio is a graduate of the University of Richmond, University of Paris, Sorbonne. He received his Medical Degree from New Jersey Medical School.

Sven Rohmann, MD, PhD, MBA

Global Chief Medical Officer – Europe.

Dr. Sven Rohmann has an excellent track record across the scientific, academic, clinical practice, and commercial areas of the industry. He spent 10 years at Merck Serono where he gained a strong foothold in the pharmaceutical industry. During his tenure at Merck, he was involved in the successful licensing of Erbitux from ImClone and the establishment of Merck Oncology. Dr. Rohmann is a leading expert in innate immunity.

In addition to his clinical expertise, he has worked across product development and marketing, as well as business development for immune health products. E.g. he was part of the management team of Biotec Pharmacon ASA, a public Norwegian company that developed soluble yeast beta-glucan for oncology indications and wound care. In 2010, Dr. Rohmann became the General Manager for Europe at Burrill & Company.

He also serves on the board or in other executive functions for several small-sized companies in Europe and the USA. Prior to joining Burrill & Company, Dr. Rohmann worked as Venture Capital Fund Manager for Novartis Pharma AG, and as Managing Partner and General Partner at Nextech Venture AG. In addition, Dr. Rohmann served as CEO, CBO and CMO of five European biotech start-ups and gained board experience at several SME's in Europe and the USA. Dr. Rohmann offers a unique blend of scientific, pharmaceutical, biotech, and venture capital knowledge.

He has an extensive global network of contacts among health care providers as well as academic and government research administrators. His thorough knowledge of European research and regulatory policies combined with his global network provides great value to iNR Wellness MD, allowing the company to expand its research activities and product portfolio globally. Dr. Rohmann received his Medical Degree from the University of Mainz, Germany, and his PhD from the Erasmus University, Rotterdam, Netherlands.